rare disease data center
Stop Using Rare Disease Data Center Do This Instead
Almost 70% of new ARC grant projects reach phase 1 trials within 12 months, showing that shifting from the Rare Disease Data Center to interoperable, AI-enabled pipelines yields faster results. This approach cuts the typical 18-month lag in target identification and aligns research with the Accelerating Rare Disease Cures (ARC)